Stay updated on AKB-9778 Tie-2 Activator Clinical Trial
Sign up to get notified when there's something new on the AKB-9778 Tie-2 Activator Clinical Trial page.

Latest updates to the AKB-9778 Tie-2 Activator Clinical Trial page
- Check7 days agoChange DetectedAdded a consolidated Locations section listing participating states and updated to revision v3.3.3. The old per-state location blocks and the HHS Vulnerability Disclosure page were removed.SummaryDifference2%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check35 days agoChange DetectedFooter revision updated from v3.2.0 to v3.3.2.SummaryDifference0.0%

- Check42 days agoChange DetectedRemoved the government funding/operating status notice/banner at the top of the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check57 days agoChange DetectedThe study details, eligibility criteria, and locations remain the same; only minor styling/layout adjustments are visible on the new page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check85 days agoChange DetectedAdded a government operating-status notice and updated version to v3.2.0; removed the previous v3.1.0 reference.SummaryDifference5%

- Check92 days agoChange DetectedAdded revision label v3.1.0; removed several MedlinePlus topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and the older revision note v3.0.2.SummaryDifference0.8%

Stay in the know with updates to AKB-9778 Tie-2 Activator Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AKB-9778 Tie-2 Activator Clinical Trial page.